-
1.发明公开
公开(公告)号：EP3712894A1
公开(公告)日：2020-09-23
申请号：EP20151174.8
申请日：2020-01-10
发明人： Yang, Joshua Sungwoo , Chon, Jaekyung , Choi, Ik Jung , Park, Hyun Min , Park, Jieun , Seo, Jeongsun , Kim, Changhoon , Seo, Han Sol , Kim, Nam Hee , Shin, Jiwon , Lee, Hye Eun , Hwang, In Hee , Sim, Seon Hye , Cho, Chang Woo , Hwang, Kyuin
IPC分类号： G16B20/00
摘要： Disclosed is a method of providing biological data. The method includes the following steps performed by a data processing device: selecting a biological data set from a biological data pool; encrypting biological data included in the biological data set to produce encrypted biological data; transferring the encrypted biological data to a user; receiving a result of analysis on the encrypted biological data from the user; and transferring information on the encrypted biological data included in the result of the analysis to the user. The data processing device encrypts the biological data with a key determined according to a combination of biological data constituting the biological data set.
-
公开(公告)号：EP3525212B1
公开(公告)日：2022-02-02
申请号：EP18212825.6
申请日：2018-12-15
-
公开(公告)号：EP3525212A1
公开(公告)日：2019-08-14
申请号：EP18212825.6
申请日：2018-12-15
发明人： YANG, Joshua Sungwoo , CHON, Jaekyung , CHOI, Ik Jung , PARK, Hyun Min , PARK, Jieun , SEO, Jeongsun , KIM, Changhoon
摘要： Disclosed is a method of providing bio-information data based on a plurality of blockchains. The method includes enabling a user blockchain node to store user block data including user information, a shared key, and a hash key for each user of a plurality of users, enabling an electronic contract blockchain node to store contract block data including contract information for a first user requesting a second user to generate bio-information data, the first user and the second user being included in the plurality of users, enabling a data transfer blockchain node to store transfer block data including storage information for at least one storage server that stores the bio-information data, and delivering the transfer block data from the data transfer blockchain node to the first user.
-
4.发明公开FUSION PROTEIN COMPRISING AXL AND COMPOSITION FOR TREATING CANCER COMPRISING SAME 有权与Axl融合蛋白组成的癌症治疗THAT
公开(公告)号：EP2894169A4
公开(公告)日：2016-03-02
申请号：EP13836076
申请日：2013-09-06
发明人： SEO JEONG-SUN , KIM YOUNG-TAE , JU YOUNG-SEOK , KIM EUN-HEE , KANG JIN-HYOUNG
CPC分类号： C12Q1/6886 , C07K14/4703 , C07K14/71 , C07K2319/00 , C12N9/12 , C12Q2600/136
摘要： Provided is a fusion protein comprising AXL receptor tyrosine kinase (AXL protein) and MAP3K12 binding inhibitory protein 1 (MBIP protein), a composition for diagnosing a cancer comprising a substance interacting with the fusion protein, a method of providing information for diagnosing a cancer using the fusion protein, a composition for preventing and/or treating a cancer comprising an inhibitor against the fusion protein, and a method for screening an anticancer agent using the fusion protein.
-
5.发明公开FUSION PROTEIN COMPRISING C-TERMINAL DOMAIN OF RET PROTEIN AND USE THEREOF AS A DIAGNOSING MARKER 审中-公开与RET蛋白的C端结构域和其作为诊断标志物的融合蛋白
公开(公告)号：EP2773673A1
公开(公告)日：2014-09-10
申请号：EP12845116.8
申请日：2012-10-31
申请人： Macrogen Inc.
发明人： JU, Young-Seok , SEO, Jeong-Sun , KIM, Eun-Hee
CPC分类号： C12N9/96 , C07K2319/03 , C12N9/12 , C12Q1/6886 , C12Q2600/156
摘要： A fusion protein including N-terminal domain of a fusion partner at N-terminal and C-terminal domain of RET protein at C-terminal, a fusion gene encoding the fusion protein, and a use of the fusion protein or the fusion gene as a diagnosing marker for a cancer, are provided.
-
6.发明公开
公开(公告)号：EP2679668A1
公开(公告)日：2014-01-01
申请号：EP11859480.3
申请日：2011-02-23
申请人： Macrogen Inc.
CPC分类号： C12P7/56 , C07C59/08 , C12N9/0006 , C12N15/74 , C12Y101/01028 , Y02P20/52
摘要： Disclosed is the biological production of lactic acid using a microorganism. A transformant capable of producing lactic acid of high optical purity at high yield, a method for the preparation thereof, and a method for producing lactic acid in a convenient and economically beneficial manner using the same are provided. The Zymomonas mobilis transformant can produce lactic acid of high optical purity at high yield without a stringent limitation to production conditions and a regulation of the intracellular metabolism pathway. Because it requires no additional separation and purification steps, the use of the transformant allows the production of lactic acid in a short process, resulting in a significant reduction in production cost, and avoiding the environment problems caused by precipitate wastes, which brings about environmental issues.
摘要翻译： 公开的是使用微生物的乳酸的生物生产。 能够以高产率制备高光学纯度的乳酸的一种转化体，提供了用于其制备，以及使用相同的便利和经济上有利的方式生产乳酸的方法的方法。 的运动发酵单胞转化体可产生高收率的高光学纯度的乳酸没有严格限制生产条件和细胞内代谢途径的调节。 因为它不需要额外的分离和纯化步骤，利用转化的允许生产乳酸在很短的过程，导致生产成本显著降低，避免了沉淀废物造成的环境问题，这带来的环境问题 ，
-
公开(公告)号：EP2228455B1
公开(公告)日：2012-07-04
申请号：EP10155167.9
申请日：2010-03-02
申请人： Macrogen Inc.
发明人： Lee, Jong-Ho , Kim, Jong-Yun , Kang, Hyun-Woong , Lee, Jung-Wan , Lee, Seung-Heui , Seo, Jeong-Sun
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/156
-
公开(公告)号：EP2228455A1
公开(公告)日：2010-09-15
申请号：EP10155167.9
申请日：2010-03-02
申请人： Macrogen Inc.
发明人： Lee, Jong-Ho , Kim, Jong-Yun , Kang, Hyun-Woong , Lee, Jung-Wan , Lee, Seung-Heui , Seo, Jeong-Sun
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/156
摘要： A diagnostic technology for breast cancer, in particular, caused by Her-2 copy number variation is provided. Said diagnostic technology identifies the amplification attributable to Her-2 copy number variations and thus allows correct, convenient and rapid diagnosis of breast cancer caused by the amplification attributable to Her-2 copy number variations. As such, said diagnostic technology is highly beneficial for customized treatments of breast cancer such as the therapy using Her-2 antibody (e.g. Herceptin).
摘要翻译： 提供了一种乳腺癌诊断技术，特别是由Her-2拷贝数变异引起的。 所述诊断技术鉴定归因于Her-2拷贝数变异的扩增，从而允许由归因于Her-2拷贝数变异引起的扩增引起的乳腺癌的正确，方便和快速诊断。 因此，所述诊断技术对于乳腺癌的定制治疗（例如使用Her-2抗体（例如赫赛汀）的治疗））是非常有益的。
-
9.发明公开METHOD AND APPARATUS FOR COMPOUND LIBRARY PREPARATION USING OPTICAL MODULATOR 审中-公开方法和装置的化合物库由光调制器是指生产
公开(公告)号：EP1180111A1
公开(公告)日：2002-02-20
申请号：EP00904105.4
申请日：2000-02-10
申请人： Macrogen Inc.
发明人： SEO, Jeong-Sun , LEE, Yoon-Sik , KIM, Yong-Kweon
IPC分类号： C07H19/00
CPC分类号： B82Y30/00 , B01J19/0046 , B01J2219/00317 , B01J2219/00436 , B01J2219/00439 , B01J2219/00527 , B01J2219/00529 , B01J2219/00585 , B01J2219/0059 , B01J2219/00596 , B01J2219/00605 , B01J2219/00612 , B01J2219/00617 , B01J2219/00621 , B01J2219/00626 , B01J2219/00637 , B01J2219/00659 , B01J2219/00689 , B01J2219/00711 , B01J2219/00722 , C07B2200/11 , C07H21/00 , C40B40/06 , C40B60/14
摘要： The present invention relates to the provision of compound libraries, more particularly it provides a compound library preparation method using an optical modulator and a compound library preparation apparatus used in the same. Furthermore, the present invention provides a compound analyzing method using the preparation method and a compound analyzing apparatus used in the same.
-
公开(公告)号：EP2894169B1
公开(公告)日：2018-05-23
申请号：EP13836076.3
申请日：2013-09-06
申请人： Macrogen, Inc.
CPC分类号： C12Q1/6886 , C07K14/4703 , C07K14/71 , C07K2319/00 , C12N9/12 , C12Q2600/136
摘要： Provided is a fusion protein comprising AXL receptor tyrosine kinase (AXL protein) and MAP3K12 binding inhibitory protein 1 (MBIP protein), a composition for diagnosing a cancer comprising a substance interacting with the fusion protein, a method of providing information for diagnosing a cancer using the fusion protein, a composition for preventing and/or treating a cancer comprising an inhibitor against the fusion protein, and a method for screening an anticancer agent using the fusion protein.
-
-
-
-
-
-
-
-
-
搜索结果
20 条记录 (耗时 0.012 秒)
